Chlorhexidine Gluconate (CHG) Wipes Market Information: by Product Type (CHG Bath Wipes, Others), by Concentration, Application, Distribution Channel, and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) — Global Forecast till 2030

Chlorhexidine Gluconate (CHG) Wipes Market Overview:

The chlorhexidine gluconate (CHG) wipes market is expected to register a CAGR of 4.78% to reach USD 13948.89 thousand till 2030. CHG wipes are antiseptic wipes that contain Chlorhexidine Gluconate (CHG). These wipes are permeated with CHG which helps to kill bacteria and prevent wound infection.

The rising number of hospital-acquired infection (HAI) cases, an increasing number of surgical procedures & surgical site infections and growing geriatric population have led to the growth of the global CHG wipes market in the recent years. However, side-effects of CHG and product recalls are likely to restrain market growth over the forecast period.

Synopsis/Market Dynamics

The World Health Organization (WHO) stated that millions of patients are affected by healthcare-associated infections worldwide each year, leading to significant mortality and financial losses. According to a report published by the European Centre for Disease Prevention and Control in June 2017, approximately 30% of the patients in ICUs are affected by at least one episode of healthcare-associated infection. This huge population affected with healthcare-acquired infections is increasing the demand for CHG Wipes and contributing to boost the growth of CHG wipes market.

Segmentation

The global CHG wipes market, by product type, has been segmented into CHG bath wipes and CHG/alcohol-based wipes. The market, by CHG concentration, can be segmented into 2% and 0.5%. On the basis of application, the global CHG wipes market is segmented into surgical site infection, central line-associated bloodstream infection, catheter-associated urinary tract infections, and lens cleaners. The CHG wipes market on the basis of distribution channel, is segmented into hospitals & retail pharmacies and online platforms. The hospital and retail pharmacies segment accounted for a value of USD 6,407.63 in 2017.

Regional Analysis

The global CHG Wipes market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is expected to dominate the global CHG Wipes market. This is owing to the increasing prevalence of patients suffering from chronic illness with rising hospital admissions for surgical procedures. Also, high healthcare spending, well-developed technology, and increasing geriatric population are some factors that are expected to drive the market growth in the region.

Europe showed a considerable amount of growth in the market due to high healthcare spending. Asia-Pacific is estimated to be the fastest growing region in the global market. Enormous opportunities for the development of CHG wipes and the presence of a huge patient population are likely to be the key factors for the growth of the Asia-Pacific CHG wipes market during the forecast period. Australia held a share of 10.7% in the Asia-Pacific CHG Wipes market in 2017. On the other hand, the Middle East and Africa has the least share of the market due to the limited availability of funds and medical facilities.

Key Players

The prominent players in the global CHG wipes market are Becton, Dickinson and Company (US), 3M (US), Cardinal Health (US), GAMA Healthcare Ltd (UK), Carenow Medical Pvt. Ltd. (India), PDI Limited (US), Lernapharm Inc. (Canada), Pal International (UK) and others.

Some of the key strategies followed by players operating in the chlorhexidine gluconate (CHG) wipes market were innovation, product development, acquisition, and expansion.

• In May 2017, GAMA Healthcare Ltd acquired the Clinell division of its Australian distributor, AMCLA Pty Ltd, in Victoria. This investment demonstrates GAMA's continued commitment to infection prevention providing outstanding education, training, and clinical support to healthcare professionals across the world.


• In October 2018, 3M announced the launch of SoluPrep Film-Forming Sterile Surgical Solution, a 2% chlorhexidine gluconate and 70% isopropyl alcohol surgical skin prep that are used to help clinicians in the fight against surgical site infections.


• In July 2017, Cardinal Health acquired Medtronic’s patient care, deep vein thrombosis, and nutritional insufficiency business (patient recovery business).

Market Segmentation

Chlorhexidine gluconate (CHG) wipes market, by Product Type

• CHG Bath Wipes


• CHG/Alcohol-Based Wipes

Chlorhexidine gluconate (CHG) wipes market, by Concentration

• 2%


• 5%

Chlorhexidine gluconate (CHG) wipes market, by Application

• Surgical Site Infection


• Central Line-Associated Bloodstream Infection


• Catheter-Associated Urinary Tract Infections


• Lens Cleaners

Chlorhexidine gluconate (CHG) wipes market, by Distribution Channel

• Hospital & Retail Pharmacies


• Online Platforms

Chlorhexidine gluconate (CHG) wipes market, by Region

• Americas




• North America




• US


• Canada




• Latin America




• Europe




• Western Europe




• Germany


• UK


• France


• Italy


• Spain


• Rest of Western Europe




• Eastern Europe




• Asia-Pacific




• China


• Japan


• India


• Australia


• South Korea


• Rest of Asia-Pacific




• Middle East & Africa




• Middle East


• Africa

Available Additional Customizations

• Company Profiles of Other Key Players


• Ecolab Inc.


• Reynard Health Supplies


• Schulke Australia Pty. Ltd


• The Clorox Company

• Investment Opportunities in the CHG Wipes Market

Intended Audience

• Pharmaceutical Companies


• Research Institutes


• Hospitals